NewcelX Ltd. (NCEL) Cash Flow Statement

NASDAQ: NCELOperating cash, capex, free cash flow and buybacks.

Where NCEL’s cash came from and went, 2025

December 31, 2025 · U.S. dollars
Cash from operations
−$2.8M
Capital expenditures
$8,000
Free cash flow
−$2.8M
Returned to shareholders
—
Change in cash
$1.6M
cash at year-end $2.2M
Acquisitions & other: $1.7MAcquisitions & other$1.7MBorrowing: $290,000Borrowing$290,000Other financing: $2.3MOther financing$2.3MCash used in operations: $2.8MCash used in operations$2.8M · 64%Added to cash: $1.6MAdded to cash$1.6M · 36%Capital expenditures, Currency & other: $20,000Other uses$20,000 · 0%$4.3M
Cash from operations
−$2.8M
Acquisitions & other
+$1.7M
Net borrowing (repayment)
+$290,000
Other financing
+$2.3M
Currency & other
−$20,000
Change in cash
$1.6M

Drawn to scale: where the cash came from and how it was used. Hover for values.

NCEL operating cash flow, capex and free cash flow

Operating cash flowCapital expendituresFree cash flowFCF margin (right axis)

NCEL cash flow trends, 2017–2025

NewcelX Ltd. cash flow trends
MetricTrendThenLatestChange
Operating cash flow−$5.4M2017−$2.8M2025—
Capital expenditures$02017$8,0002025—
Free cash flow−$5.4M2017−$2.8M2025—
Stock-based compensation$782017$765,0002025+895.4%/yr

Change is the average annual growth (CAGR) or the difference between the first and latest year.

NCEL cash flow by activity

OperatingInvestingFinancingChange in cash

NCEL net income vs operating cash flow

Net incomeOperating cash flow

Operating cash flow above net income usually means earnings are backed by cash (depreciation and stock-based pay are non-cash expenses).

NCEL cash flow statement

NewcelX Ltd. annual cash flow statement
20252020201920182017
Operating activities
Net income−$8.3M−$2.9M−$5.4M−$5.1M−$6.7M
Depreciation & amortization$55,000$72.2M—$1.1M—
Stock-based compensation$765,000———$78
Change in working capital−$1.1M$2.1M$4.1M$101,902$340,287
Other non-cash items$5.8M−$72.1M$1.1M$1.2M$884,309
Cash from operating activities−$2.8M−$729,386−$190,009−$2.7M−$5.4M
Investing activities
Capital expenditures−$8,000−$4$0$0$0
Acquisitions & other investing$1.7M$225,642−$217,252——
Cash from investing activities$1.7M$225,638−$217,252——
Financing activities
Net borrowing (repayment)$290,000————
Shares issued$0$0$0$0$0
Other financing$2.3M$503,522$407,479$557,920$6.7M
Cash from financing activities$2.6M$503,522$407,479$557,920$6.7M
Summary
Net change in cash$1.6M−$126,557$213,589−$2.2M$1.3M
Cash at end of period$2.2M$93,710$220,267$6,678$2.2M
Free cash flow−$2.8M−$729,386−$190,009−$2.7M−$5.4M

Negative numbers are cash paid out. Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported; data from EODHD.

NCEL cash generation

In fiscal 2025 (ended December 31, 2025), NewcelX generated -$2.8 million of cash from operations and spent $0.0 million on capital expenditures, leaving free cash flow of -$2.8 million. Cash and equivalents rose by $1.6 million over the year.

Related: NCEL income statement, NCEL balance sheet. See the NCEL stock overview for the latest quote and news.

NCEL cash flow FAQ

What is NewcelX's free cash flow?

NewcelX's free cash flow was -$2.8 million in fiscal 2025: -$2.8 million of operating cash flow minus $0.0 million of capital expenditures It was -$0.7 million a year earlier..

How much cash does NewcelX generate from operations?

NewcelX generated -$2.8 million of cash from operating activities in fiscal 2025.

How much does NewcelX spend on capital expenditures?

NewcelX spent $0.0 million on capital expenditures in fiscal 2025, compared with $0.0 million the year before.

Biotechnology: cash flow